982879.fig.001
Figure 1: Targeted RTK and their signal transduction routes in head and neck cancer. The EGFR, Met, and IGF-1R receptors and their prototypic ligands are shown. Cysteine-rich domains (red box) and fibronectin type III-like domain (grey box) are indicated in the extracellular domains of the EGFR and IGF-1R, respectively. Cytoplasmic tyrosine kinase domains for each receptor are indicated (green boxes). The symbols and denote distinct RTK subunits. Targeted humanized monoclonal antibodies for extracellular components (white box) and TKIs (black box) for each receptor signaling axis is shown.